Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)

NCT03643952 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacteremia
Soft Tissue Infections
Skin Diseases, Infectious

Interventions

DRUG: Daptomycin for Injection

Sponsor

Merck Sharp & Dohme LLC